Labat Africa to acquire Biodata in bid to grow cannabis business

SOUTH AFRICA – Labat Cannabis South Africa, an investment holding company of the entire Labat cannabis supply and value chain, is set to acquire a 70% stake in Biodata, a technology and medical research company focused on the cannabis industry which is estimated to be worth R27 billion (US$1.44bn). “The proposed acquisition of Biodata provides Labat Africa with additional medical and pharmaceutical infrastructure in support of its health-care strategy. Gallow and her team will also provide expertise and value to Labat Africa’s endeavours to developing the company’s drug master files…

Read More